Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Galectin-3 cleavage alters bone remodeling: Different outcomes in breast and prostate cancer skeletal metastasis.

Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A.

Cancer Res. 2016 Feb 2. pii: canres.1793.2015. [Epub ahead of print]

PMID:
26837763
2.

Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis.

Wu RL, Ali S, Bandyopadhyay S, Alosh B, Hayek K, Daaboul MF, Winer I, Sarkar FH, Ali-Fehmi R.

J Cancer Sci Ther. 2015;7(7):258-265.

3.

Can problematic fibroepithelial lesions be accurately classified on core needle biopsies?

Bandyopadhyay S, Barak S, Hayek K, Thomas S, Saeed H, Beydoun R, Shi D, Arabi H, Ruterbusch J, Cote M, Ali-Fehmi R.

Hum Pathol. 2016 Jan;47(1):38-44. doi: 10.1016/j.humpath.2015.09.001. Epub 2015 Sep 21.

PMID:
26521710
4.

The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1407-15. doi: 10.1158/1055-9965.EPI-15-0316. Epub 2015 Aug 19.

PMID:
26290568
5.

Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma.

Roma AA, Rybicki LA, Barbuto D, Euscher E, Djordjevic B, Frauenhoffer E, Kim I, Hong SR, Montiel D, Ali-Fehmi R, Malpica A, Silva EG.

Hum Pathol. 2015 Oct;46(10):1529-39. doi: 10.1016/j.humpath.2015.06.015. Epub 2015 Jun 30.

PMID:
26264257
6.

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.

Bollig-Fischer A, Michelhaugh SK, Wijesinghe P, Dyson G, Kruger A, Palanisamy N, Choi L, Alosh B, Ali-Fehmi R, Mittal S.

Oncotarget. 2015 Jun 10;6(16):14614-24.

7.

Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.

Al-Wahab Z, Mert I, Tebbe C, Chhina J, Hijaz M, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R.

Oncotarget. 2015 May 10;6(13):10908-23.

8.

PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.

Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, Ali-Fehmi R, Coleman RL, Sood AK.

Mol Cancer Ther. 2015 Jun;14(6):1466-75. doi: 10.1158/1535-7163.MCT-14-1077. Epub 2015 Apr 1.

PMID:
25833835
9.

Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance.

Roma AA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R, Rutgers JK, Barbuto D, Silva EG.

Am J Surg Pathol. 2015 May;39(5):667-72. doi: 10.1097/PAS.0000000000000402.

PMID:
25724003
10.

The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study.

Winer I, Alvarado-Cabrero I, Hassan O, Ahmed QF, Alosh B, Bandyopadhyay S, Thomas S, Albayrak S, Talukdar S, Al-Wahab Z, Elshaikh MA, Munkarah A, Morris R, Ali-Fehmi R.

Gynecol Oncol. 2015 Jun;137(3):474-8. doi: 10.1016/j.ygyno.2015.02.005. Epub 2015 Feb 10.

PMID:
25677061
11.

Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.

Mahdi H, Elshaikh MA, DeBenardo R, Munkarah A, Isrow D, Singh S, Waggoner S, Ali-Fehmi R, Morris RT, Harding J, Moslemi-Kebria M.

Gynecol Oncol. 2015 May;137(2):239-44. doi: 10.1016/j.ygyno.2015.01.544. Epub 2015 Jan 29.

PMID:
25641568
12.

Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.

Mahdi H, Rose PG, Elshaikh MA, Munkarah A, Isrow D, Singh S, Waggoner S, Ali-Fehmi R, Morris RT, Harding J, DeBenardo R.

Gynecol Oncol. 2015 Mar;136(3):529-33. doi: 10.1016/j.ygyno.2014.12.034. Epub 2015 Jan 7.

PMID:
25575483
13.

Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.

Mahdi H, Munkarah AR, Ali-Fehmi R, Woessner J, Shah SN, Moslemi-Kebria M.

Arch Gynecol Obstet. 2015 Jul;292(1):183-90. doi: 10.1007/s00404-014-3609-6. Epub 2014 Dec 31.

PMID:
25549769
14.

Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.

Ahmed QF, Gattoc L, Al-Wahab Z, Abdulfatah E, Ruterbusch JJ, Cote M, Bandyopadhyay S, Morris RT, Ali-Fehmi R.

Am J Surg Pathol. 2015 Feb;39(2):221-6. doi: 10.1097/PAS.0000000000000361.

PMID:
25517962
15.

Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.

Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, Ali-Fehmi R, Rose PG, Munkarah AR.

Gynecol Oncol. 2015 Feb;136(2):235-9. doi: 10.1016/j.ygyno.2014.12.012. Epub 2014 Dec 12.

PMID:
25511158
16.

Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?

Winer I, Ahmed QF, Mert I, Bandyopadhyay S, Cote M, Munkarah AR, Hussein Y, Al-Wahab Z, Elshaikh MA, Alosh B, Schultz DS, Mahdi H, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R.

Int J Gynecol Pathol. 2015 Jan;34(1):47-56. doi: 10.1097/PGP.0000000000000113.

PMID:
25473753
17.

Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML.

Breast J. 2014 Nov-Dec;20(6):571-7. doi: 10.1111/tbj.12331. Epub 2014 Sep 8.

18.

Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.

Ahmad A, Sethi S, Chen W, Ali-Fehmi R, Mittal S, Sarkar FH.

Am J Transl Res. 2014 Jul 18;6(4):384-90. eCollection 2014.

19.

Dietary energy balance modulates ovarian cancer progression and metastasis.

Al-Wahab Z, Tebbe C, Chhina J, Dar SA, Morris RT, Ali-Fehmi R, Giri S, Munkarah AR, Rattan R.

Oncotarget. 2014 Aug 15;5(15):6063-75.

20.

The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036. Epub 2014 Jun 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk